Trinity first began offering transcatheter aortic valve replacement as an alternative to open-heart surgery in 2021.
TAVR entails putting a catheter through the patient’s blood vessel to push out and replace the heart’s malfunctioning aortic valve.
The median length of stay for Trinity’s TAVR patients is 1.2 days, according to the report.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
